BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37202577)

  • 21. Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases.
    Su W; Yu Y; Xu X; Wang XQ; Huang JB; Xu CD; Xiao Y
    World J Gastroenterol; 2021 Jan; 27(1):92-106. PubMed ID: 33505153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying Mutations of the Tetratricopeptide Repeat Domain 37 (TTC37) Gene in Infants With Intractable Diarrhea and a Comparison of Asian and Non-Asian Phenotype and Genotype: A Global Case-report Study of a Well-Defined Syndrome With Immunodeficiency.
    Lee WI; Huang JL; Chen CC; Lin JL; Wu RC; Jaing TH; Ou LS
    Medicine (Baltimore); 2016 Mar; 95(9):e2918. PubMed ID: 26945392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
    Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing.
    Dinwiddie DL; Bracken JM; Bass JA; Christenson K; Soden SE; Saunders CJ; Miller NA; Singh V; Zwick DL; Roberts CC; Dalal J; Kingsmore SF
    Genomics; 2013; 102(5-6):442-7. PubMed ID: 24001973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study.
    Usami M; Takeuchi I; Kyodo R; Hirano Y; Kashiwagi K; Fujikawa H; Shimizu H; Kawai T; Arai K
    Intest Res; 2022 Oct; 20(4):475-481. PubMed ID: 35686293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel
    Lee WI; Fan WL; Lu CH; Chen SH; Kuo ML; Lin SJ; Tsai WS; Jaing TH; Chen LC; Yeh KW; Yao TC; Huang JL
    Front Immunol; 2019; 10():2833. PubMed ID: 31921117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Miller TL; Lee D; Giefer M; Wahbeh G; Suskind DL
    Dig Dis Sci; 2017 Aug; 62(8):2196-2200. PubMed ID: 28551707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics,
    Chen YE; Chen J; Guo W; Zhang Y; Li J; Xie H; Shen T; Ge Y; Huang Y; Zheng W; Lu M
    Front Genet; 2022; 13():921808. PubMed ID: 35783276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.
    Angelino G; De Angelis P; Faraci S; Rea F; Romeo EF; Torroni F; Tambucci R; Claps A; Francalanci P; Chiriaco M; Di Matteo G; Cancrini C; Palma P; D'Argenio P; Dall'Oglio L; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2017 Dec; 28(8):801-809. PubMed ID: 28981976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Jardine S; Anderson S; Babcock S; Leung G; Pan J; Dhingani N; Warner N; Guo C; Siddiqui I; Kotlarz D; Dowling JJ; Melnyk RA; Snapper SB; Klein C; Thiagarajah JR; Muise AM
    Gastroenterology; 2020 Mar; 158(4):1000-1015. PubMed ID: 31743734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea.
    Tronstad RR; Polushina T; Brattbakk HR; Stansberg C; von Volkmann HL; Hanevik K; Ellinghaus E; Jørgensen SF; Ersland KM; Pham KD; Gilja OH; Hovdenak N; Hausken T; Vatn MH; Franke A; Knappskog PM; Le Hellard S; Karlsen TH; Fiskerstrand T
    Scand J Gastroenterol; 2018; 53(10-11):1264-1273. PubMed ID: 30353760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very-Early Onset Chronic Active Colitis with Heterozygous Variants in
    He M; Wong A; Sutton K; Gondim MJB; Samson C
    Fetal Pediatr Pathol; 2023 Apr; 42(2):297-306. PubMed ID: 35748740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.
    Conrad MA; Kelsen JR
    Pediatr Dev Pathol; 2019; 22(3):183-193. PubMed ID: 30841788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease.
    Zhu L; Shi T; Zhong C; Wang Y; Chang M; Liu X
    Gastroenterology Res; 2017 Apr; 10(2):65-69. PubMed ID: 28496525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity.
    Azizi G; Bagheri Y; Yazdani R; Zaki-Dizaji M; Jamee M; Jadidi-Niaragh F; Kamali AN; Abolhassani H; Aghamohammadi A
    Allergol Immunopathol (Madr); 2019; 47(2):172-178. PubMed ID: 30193889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
    Merkley SA; Beaulieu DB; Horst S; Duley C; Annis K; Nohl A; Schwartz DA
    Inflamm Bowel Dis; 2015 Aug; 21(8):1854-9. PubMed ID: 25993689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area.
    Yeh PJ; Chen CC; Chao HC; Lai JY; Hsueh C; Wang CJ; Lai MW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):720-727. PubMed ID: 32819795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease.
    Okou DT; Mondal K; Faubion WA; Kobrynski LJ; Denson LA; Mulle JG; Ramachandran D; Xiong Y; Svingen P; Patel V; Bose P; Waters JP; Prahalad S; Cutler DJ; Zwick ME; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):561-8. PubMed ID: 24792626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases.
    Horton N; Kochhar G; Patel K; Lopez R; Shen B
    Inflamm Bowel Dis; 2017 Jul; 23(7):1080-1087. PubMed ID: 28452863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.